Clean Power Hydrogen (LSE:CPH2) said on 5 June 2026 that its 1MW electrolyser was irreparably damaged during factory acceptance testing, and that the board would not resume the test programme. With trading in its AIM shares suspended and a warning of material uncertainty over its future, the company is now pursuing non-manufacturing commercial strategies.

What the company does

Clean Power Hydrogen describes itself as a UK-based green hydrogen technology and Manufacturing company. Its MFE220 is a 1MW electrolyser designed to produce hydrogen using its own mixed gas system. The company cites six Patent families across twelve countries, along with licensees, copyrights, designs, schematics and more than a decade of technical know-how.

Latest developments

An incident occurred during a standard shutdown procedure in the third and final stage of factory acceptance testing, known as FAT3, of the MFE220 unit. The company first reported it on 29 May 2026 and suspended operations. In the 5 June update it said a later inspection found significant damage that could not be repaired to allow testing to continue. The cause is still being investigated.

The board decided not to restart FAT3. The chief technology officer and chief operating officer advised that the MFE220 would need substantial redesign before its mixed gas system could operate safely, and LSE:CPH2 said it lacks the resources to pursue that at this time. The board retains confidence in the technology's potential, and is evaluating Options to maximise the value of its intellectual property, including licensing and strategic alternatives. Insurers were notified and have visited the site to start their assessment.

Earlier in 2026 LSE:CPH2 had been more upbeat. It announced memoranda of understanding with Siemens on 24 March, with Koch Modular on 7 April and with ABE Gruppe, as well as operational and trading updates, and a Capital injection of £2.54 million was reported on resumption of trading at an earlier point.

Financial picture

The 5 June announcement gave no cash balance or funding amounts. It said Working Capital remains constrained, that there is material uncertainty over continuing operations and that discussions with capital providers are continuing. The scale of insurance cover and any recovery are not known. As a pre-revenue manufacturer, the company has relied on fundraisings, and no Dividend can be expected. Investors should consult the annual report, which was posted along with a notice of AGM in 2026, for the accounts.

Sector and index context

Clean Power Hydrogen (LSE:CPH2) is one of the few hydrogen technology companies on the FTSE AIM All Share Index. The sector has faced a difficult environment, with ambitious targets set by governments but project finance slow to arrive, and electrolyser makers competing with larger European, American and Chinese suppliers. Safety is critical in hydrogen, so technical failures carry weight beyond the immediate cost.

Key risks

The company's central risk is survival. Suspension of trading, constrained working capital and the loss of its main demonstration unit all raise doubts. A pivot away from manufacturing may reduce its prospects of earning product revenue, and licensing depends on finding partners willing to pay for technology that has not completed testing. Insurance outcomes are uncertain, and further fundraising may be difficult.

What to watch next

Shareholders will look for news on the cause of the incident, the insurance assessment, funding discussions and any decision on licensing or a sale of intellectual property. A restoration of trading or a move to cancel the AIM listing would be significant.